Millennium Pharmaceuticals News

Drug developer Millennium: The Takeda Oncology Co. has agreed to pay up to $365 million in a deal to develop and commercialize a potential cancer therapy being tested by Seattle Genetics Inc.

Seattle Genetics and Millennium: The Takeda Oncology Company have entered into an agreement to globally develop and commercialize brentuximab vedotin , an antibody-drug conjugate targeting CD30.

All times in Eastern Time. NEW ORLEANS-- --Millennium: The Takeda Oncology Company today reported updated results based on a planned median three-year follow up of patients from the large, international Phase III... BOTHELL, Washington-- --SonoSite Inc., societa leader a livello mondiale specializzata in apparecchi ecografici portatili per l'uso ...

Dec 8, 2009 - Millennium: The Takeda Oncology Company today reported data from a clinical trial evaluating a VELCADE based combination for patients with relapsed/refractory non-Hodgkin's lymphoma .

Dec 7, 2009 - Millennium: The Takeda Oncology Company today reported the presentation of results from a double randomized Phase III clinical trial of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma .

These abstracts include an oral presentation of data on successful VELCADE utilization in both induction and maintenance in the front-line setting during the distinguished plenary session being held on Sunday, December 6. The ASH Program Committee selects for the plenary session the most ground-breaking abstracts of the conference.

CleanTech Stan Haftka has been named director of business development, Europe, for Telles, the joint venture between Cambridge-based Metabolix Inc.

Osaka-based Takeda Pharmaceutical Co. may consider acquisitions in South America and is interested in expanding in generic drugs, President Yasuchika Hasegawa said yesterday.

Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Companya s second-generation proteasome inhibitor.

The winners of the Millennium Excellence National In-course Awards for Conestoga College were recognized at the latest board of governors meeting on Oct.

But the 500-year-old college, one of the wealthiest academic institutions, has bought The O2, London 's top music venue, where Led Zeppelin staged their famous comeback and Michael Jackson planned to do so, too.

IF THERE'S ONE THING that's essential for getting work done, it might be coffee.

Alnara Pharmaceuticals , a privately held Cambridge, Mass.-based biotechnology company with a late stage cystic fibrosis drug target, has appointed its first chief medical director.

Keiko Sakurai held up a business card for her audience of 20 biotechnology managers whose company, Millennium Pharmaceuticals Inc.

Takeda Pharmaceutical Co. , maker of the worlda s best-selling diabetes drug Actos, posted first-half profit that more than doubled on lower expenses, while cutting its revenue outlook because of weaker sales and the stronger yen.

Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Cancer / Oncology Clinical Trials / Drug Trials Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone with or without VELCADE for Injection for patients with a ...

Protein-focused biotech company Aileron Therapeutics Inc. has named Steven Kafka as its chief financial officer and vice president of finance and operations.

WOULD you like to improve your chances of winning the National Lottery? Well at expert mathematician will be telling students this week how they can do just that.

Cambridge's Trinity College has acquired Meridian Delta Dome, the company that holds the 999 year lease on London's Millennium Dome, for 24 million pounds.

The wealthiest Cambridge college has bought into the O2 Arena in London in a 24 million deal.